Latest news for Sugi Holdings Co (OTC:SGIPF) Stock

Sugi Holdings Co Ltd generates revenue through pharmaceutical care in Japan. The company's drug stores sell prescription and generic drugs along with general merchandise including premium and discount groceries, discount cosmetics, pet supplies, and health supplements that are designed for self-medication. Sugi Holdings also provides disease prevention and drug delivery services. The company's Cedar Pharmacy group operates regional drugstores designed for providing health consultation. Sugi Holdings also supports regional healthcare facilities and provides at-home nursing services.

Sugi Holdings Co Ltd

Sugi Holdings Co (SGIPF – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Sho Kawano fro...

Sugi Holdings Co.: Strong Quarterly Performance and Strategic Growth Initiatives Prompt a Buy Rating

Sugi Holdings Co (JP:7649) has released an update. In June 2024, Sugi Holdings Co. Ltd. reported a 6.9% increase in existing-store sales, with the ...

Sugi Holdings Reports Robust Sales Growth in June

Sugi Holdings Co (JP:7649) has released an update. Sugi Holdings Co., Ltd. has announced upcoming management changes at its soon-to-be subsidiary, ...

Sugi Holdings Announces Strategic Management Reorganization

Sugi Holdings Co (JP:7649) has released an update. Sugi Holdings Co. Ltd announces a partial change to its previous disclosure regarding the acquis...

Sugi Holdings Updates Share Acquisition Details

Harris Associates Japan Strategy  Q2 2024 Commentary

Sugi Holdings Co (JP:7649) has released an update. Sugi Holdings Co., Ltd. has reported a robust financial performance for the first half of the fi...

Sugi Holdings Reports Strong Half-Year Financial Growth

Sugi Holdings Co (JP:7649) has released an update. Sugi Holdings Co. Ltd. reports a 2.8% increase in existing-store sales and a 17.2% increase in a...

Comments

Sugi Holdings Co

News

Latest news for Sugi Holdings Co (OTC:SGIPF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga